De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival

Bronchiectasis occurs de novo in haematological malignancy and is associated with significant mortality and morbidity. Rituximab predisposes to IgG deficiency and survival time is significantly associated with age, FEV(1) % and stem cell transplantation. http://bit.ly/2KZwCZt

Detalles Bibliográficos
Autores principales: José, Ricardo J., Hall, Jocelin, Brown, Jeremy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826250/
https://www.ncbi.nlm.nih.gov/pubmed/31720297
http://dx.doi.org/10.1183/23120541.00166-2019
_version_ 1783465044114145280
author José, Ricardo J.
Hall, Jocelin
Brown, Jeremy S.
author_facet José, Ricardo J.
Hall, Jocelin
Brown, Jeremy S.
author_sort José, Ricardo J.
collection PubMed
description Bronchiectasis occurs de novo in haematological malignancy and is associated with significant mortality and morbidity. Rituximab predisposes to IgG deficiency and survival time is significantly associated with age, FEV(1) % and stem cell transplantation. http://bit.ly/2KZwCZt
format Online
Article
Text
id pubmed-6826250
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-68262502019-11-12 De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival José, Ricardo J. Hall, Jocelin Brown, Jeremy S. ERJ Open Res Original Research Letters Bronchiectasis occurs de novo in haematological malignancy and is associated with significant mortality and morbidity. Rituximab predisposes to IgG deficiency and survival time is significantly associated with age, FEV(1) % and stem cell transplantation. http://bit.ly/2KZwCZt European Respiratory Society 2019-11-04 /pmc/articles/PMC6826250/ /pubmed/31720297 http://dx.doi.org/10.1183/23120541.00166-2019 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Research Letters
José, Ricardo J.
Hall, Jocelin
Brown, Jeremy S.
De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival
title De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival
title_full De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival
title_fullStr De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival
title_full_unstemmed De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival
title_short De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival
title_sort de novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival
topic Original Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826250/
https://www.ncbi.nlm.nih.gov/pubmed/31720297
http://dx.doi.org/10.1183/23120541.00166-2019
work_keys_str_mv AT josericardoj denovobronchiectasisinhaematologicalmalignanciespatientcharacteristicsriskfactorsandsurvival
AT halljocelin denovobronchiectasisinhaematologicalmalignanciespatientcharacteristicsriskfactorsandsurvival
AT brownjeremys denovobronchiectasisinhaematologicalmalignanciespatientcharacteristicsriskfactorsandsurvival

Ejemplares similares